EVOcells
Integrated iPSC-based platform for cell therapy discovery, development, and manufacturing.
Executive Summary
EVOcells is Evotec's integrated and versatile cell therapy platform, leveraging proprietary and best-in-class induced Pluripotent Stem Cell (iPSC) technology. It covers the entire spectrum from discovery and development to manufacturing of cell therapies, providing a comprehensive solution for advancing therapeutic candidates. The platform is designed to broaden and deepen Evotec's efforts in cell therapy, with a specific focus on oncology and inflammation & immunology (I&I) applications, utilizing iPSC-based immune effector cells. Evotec continuously expands EVOcells' capabilities, as demonstrated by strategic licensing agreements to enhance its technological offerings. A key component of EVOcells is its high-quality cGMP manufacturing facility, ensuring the production of cell therapies meets stringent regulatory standards. This integrated approach aims to accelerate timelines, reduce risks, and enhance cost-efficiency in the delivery of innovative cell therapies.
Use Cases
- Discovery of novel cell therapies
- Development of iPSC-based cell therapies
- Manufacturing of cGMP-compliant cell therapies
- Oncology applications using iPSC-based immune effector cells
- Inflammation & Immunology (I&I) applications using iPSC-based immune effector cells
Features
Intelligence
- Proprietary iPSC Technology: Utilizes Evotec's best-in-class induced Pluripotent Stem Cell (iPSC) technology as the foundation for cell therapy development.
- Oncology & I&I Focus: Specialized development of iPSC-based immune effector cells for therapeutic applications in oncology and inflammation & immunology.
Technical Specifications
Integrations
- panCELLa
Pricing
- Starting Price
- Contact sales
- Target Customer
- Mid-Market,Enterprise
- Free Trial
- No
About Evotec
Evotec is a life science company pioneering drug discovery and development by integrating breakthrough science with AI-driven innovation and advanced technologies. They accelerate the journey from concept to cure, offering drug discovery alliance and development services for the biopharma sector. Evotec partners with pharmaceutical and biotechnology companies, academic institutions, and other healthcare stakeholders globally.